Back to Agenda
Session 2: Patient Perspectives on the Risks and Benefits of Opioid Therapy
Session Chair(s)
Robert Pratt
Risk Management Analyst
FDA, United States
Balancing the risks of opioid therapy with the benefits is an ongoing challenge as prescription opioids continue to contribute to the US opioid crisis. This session examines the patient's understanding, attitudes, and experiences with opioids including concepts of misuse and abuse, communication of risk, and the benefit-risk perspective. Panelists will also discuss strategies to minimize risk as well as challenges with patient engagement in this setting.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the patient’s perspective, experiences, and informational needs about opioids
- Describe a self-reported measure to identify opioid abuse and misuse behaviors
- Understand risk assessment and mitigation strategies for the use of opioids in patients with chronic pain
Speaker(s)
Opioid Therapy in Patients with Chronic Pain: Present and Future of Risk Assessment and Mitigation
Martin Cheatle, PhD
Perelman School of Medicine, University of Pennsylvania, United States
Associate Professor of Psychology in Psychiatry
Validating a Self-Report Measure of Prescription Opioid Misuse and Abuse (the POMAQ) in Patients with Chronic Noncancer Pain: Pathways to Success
Karin Coyne, PhD, MPH
Evidera, United States
Vice President, Research
Measuring Safety and Success: The Consumer Perspective
Nicole Kelly
American Chronic Pain Association, United States
Exploring Patient Knowledge, Attitudes, and Behaviors to Aid Development of the Information They Need and Want About Opioid Analgesics
Paula Rausch, PhD, RN
FDA, United States
Director, Division of Health Communications, Office of Communications, CDER
Have an account?